X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (231) 231
humans (204) 204
oncology (126) 126
melanoma (115) 115
female (102) 102
male (96) 96
middle aged (83) 83
melanoma - genetics (82) 82
adult (80) 80
cancer (74) 74
melanoma - drug therapy (70) 70
aged (68) 68
mutation (68) 68
cell biology (59) 59
melanoma - pathology (56) 56
proto-oncogene proteins b-raf - genetics (45) 45
proto-oncogene proteins b-raf - antagonists & inhibitors (42) 42
aged, 80 and over (38) 38
skin neoplasms - genetics (38) 38
skin neoplasms - pathology (38) 38
research (36) 36
dermatology (35) 35
survival (34) 34
treatment outcome (32) 32
metastatic melanoma (30) 30
vemurafenib (30) 30
braf (29) 29
mutations (28) 28
young adult (28) 28
animals (27) 27
adolescent (26) 26
article (26) 26
cell line, tumor (26) 26
skin neoplasms - drug therapy (26) 26
tumors (26) 26
antineoplastic agents - therapeutic use (25) 25
care and treatment (25) 25
genetic predisposition to disease (25) 25
metastasis (25) 25
risk factors (25) 25
australia (24) 24
cutaneous melanoma (24) 24
immunotherapy (24) 24
dabrafenib (23) 23
melanoma - metabolism (22) 22
melanoma - secondary (22) 22
neoplasm staging (22) 22
biochemistry & molecular biology (21) 21
gene (21) 21
ipilimumab (21) 21
medical research (21) 21
prognosis (21) 21
malignant-melanoma (19) 19
medicine, general & internal (19) 19
melanoma - mortality (19) 19
solid tumors (19) 19
biology (18) 18
case-control studies (18) 18
genes (18) 18
genetics & heredity (18) 18
imidazoles - administration & dosage (18) 18
neoplasms (18) 18
open-label (18) 18
oximes - administration & dosage (18) 18
protein kinase inhibitors - therapeutic use (18) 18
abridged index medicus (17) 17
disease-free survival (16) 16
drug therapy (16) 16
risk (16) 16
apoptosis (15) 15
genetic aspects (15) 15
imidazoles - therapeutic use (15) 15
immunohistochemistry (15) 15
metastases (15) 15
neoplasm metastasis (15) 15
neoplasms - genetics (15) 15
oximes - therapeutic use (15) 15
resistance (15) 15
safety (15) 15
cell line (14) 14
clinical trials (14) 14
cutaneous malignant-melanoma (14) 14
improved survival (14) 14
multidisciplinary sciences (14) 14
patients (14) 14
risk assessment (14) 14
salinity (14) 14
sulfonamides - therapeutic use (14) 14
therapy (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
melanoma - epidemiology (13) 13
skin cancer (13) 13
analysis (12) 12
cells (12) 12
disease progression (12) 12
expression (12) 12
gene mutations (12) 12
indoles - therapeutic use (12) 12
p16 (12) 12
skin neoplasms - epidemiology (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 04/2011, Volume 29, Issue 10, pp. 1239 - 1246
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 03/2019, Volume 25, Issue 5, pp. 1557 - 1563
Purpose: Combination PD-1 and CTLA-4 inhibitor therapy has dramatically improved the survival of patients with advanced melanoma but is also associated with... 
SURVIVAL | INTERLEUKIN-2 | MIGRATION | PEMBROLIZUMAB | ONCOLOGY | CHEMOKINES | COMBINED NIVOLUMAB | RECEPTORS | TUMORS | ADVERSE EVENTS | IPILIMUMAB
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 765 - 765
Journal Article
by Akbani, Rehan and Akdemir, Kadir C and Aksoy, B. Arman and Albert, Monique and Ally, Adrian and Amin, Samirkumar B and Arachchi, Harindra and Arora, Arshi and Auman, J. Todd and Ayala, Brenda and Baboud, Julien and Balasundaram, Miruna and Balu, Saianand and Barnabas, Nandita and Bartlett, John and Bartlett, Pam and Bastian, Boris C and Baylin, Stephen B and Behera, Madhusmita and Belyaev, Dmitry and Benz, Christopher and Bernard, Brady and Beroukhim, Rameen and Bir, Natalie and Black, Aaron D and Bodenheimer, Tom and Boice, Lori and Boland, Genevieve M and Bono, Riccardo and Bootwalla, Moiz S and Bosenberg, Marcus and Bowen, Jay and Bowlby, Reanne and Bristow, Christopher A and Brockway-Lunardi, Laura and Brooks, Denise and Brzezinski, Jakub and Bshara, Wiam and Buda, Elizabeth and Burns, William R and Butterfield, Yaron S.N and Button, Michael and Calderone, Tiffany and Cappellini, Giancarlo Antonini and Carter, Candace and Carter, Scott L and Cherney, Lynn and Cherniack, Andrew D and Chevalier, Aaron and Chin, Lynda and Cho, Juok and Cho, Raymond J and Choi, Yoon-La and Chu, Andy and Chudamani, Sudha and Cibulskis, Kristian and Ciriello, Giovanni and Clarke, Amanda and Coons, Stephen and Cope, Leslie and Crain, Daniel and Curley, Erin and Danilova, Ludmila and D’Atri, Stefania and Davidsen, Tanja and Davies, Michael A and Delman, Keith A and Demchok, John A and Deng, Qixia A and Deribe, Yonathan Lissanu and Dhalla, Noreen and Dhir, Rajiv and DiCara, Daniel and Dinikin, Michael and Dubina, Michael and Ebrom, J. Stephen and Egea, Sophie and Eley, Greg and Engel, Jay and Eschbacher, Jennifer M and Fedosenko, Konstantin V and Felau, Ina and Fennell, Timothy and Ferguson, Martin L and Fisher, Sheila and Flaherty, Keith T and Frazer, Scott and Frick, Jessica and Fulidou, Victoria and Gabriel, Stacey B and Gao, Jianjiong and Gardner, Johanna and Garraway, Levi A and Gastier-Foster, Julie M and Gaudioso, Carmelo and Gehlenborg, Nils and Genovese, Giannicola and Gerken, Mark and Gershenwald, Jeffrey E and Getz, Gad and ... and Canc Genome Atlas Network and Cancer Genome Atlas Network
Cell, ISSN 0092-8674, 06/2015, Volume 161, Issue 7, pp. 1681 - 1696
Journal Article
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 11/2018
Combination PD-1 and CTLA-4 inhibitor therapy has dramatically improved the survival of patients with advanced melanoma but is also associated with significant... 
Journal Article
Medical Journal of Australia, ISSN 0025-729X, 11/2012, Volume 197, Issue 9, pp. 491 - 492
Journal Article
Lancet, ISSN 0140-6736, 02/2005, Volume 365, Issue 9460, pp. 687 - 701
Episodic exposure of fair-skinned individuals to intense sunlight is thought to be responsible for the steadily increasing melanoma incidence worldwide over... 
Journal Article
Journal Article
Journal Article
Nature, ISSN 0028-0836, 05/2017, Volume 545, Issue 7653, pp. 175 - 180
Melanoma of the skin is a common cancer only in Europeans, whereas it arises in internal body surfaces (mucosal sites) and on the hands and feet (acral sites)... 
TERT PROMOTER MUTATIONS | UVEAL MELANOMA | SEQUENCE DATA | MULTIDISCIPLINARY SCIENCES | RECURRENT MUTATIONS | FREQUENT SOMATIC MUTATIONS | MALIGNANT-MELANOMA | GENERAL FRAMEWORK | CANCER GENOMES | ACTIVATING MUTATIONS | DRIVER MUTATIONS | Membrane Proteins - genetics | Humans | X-linked Nuclear Protein | Phosphoproteins - genetics | RNA Splicing Factors - genetics | Mutation - genetics | Genes, p16 | Genome, Human - genetics | Tumor Suppressor Protein p53 - genetics | Ultraviolet Rays - adverse effects | Telomerase - genetics | Signal Transduction - drug effects | GTP Phosphohydrolases - genetics | Melanoma - genetics | Proto-Oncogene Proteins B-raf - genetics | Mitogen-Activated Protein Kinases - genetics | Neurofibromatosis 1 - genetics | Melanoma - classification | Nuclear Proteins - genetics | DNA Helicases - genetics | Telomere - genetics | Genetic research | Genetic aspects | Genomes | Research | Melanoma | Pathogenesis | Copy number | Mucosa | p53 Protein | Radiation | Security | Epidemiology | Metastases | Reproduction (copying) | Coding | Mismatch repair | Clusters | Eye (anatomy) | Fellowships | Deoxyribonucleic acid--DNA | Medical research | Breakpoints | Radiation effects | MAP kinase | Exposure | Sun | Amplification | Bridges | Pathology | Ultraviolet radiation | Mutagenesis | Computation | Skin | Mutation | Internet | Aberration | Biotechnology | Genes | DNA damage | Carcinogens | Infrastructure | Signatures | Health | U.V. radiation | Inversions | Foldback | Data processing | Energy policy | Readers | Deamination | Protein kinase | Cell lines | Gene mapping | Tumors | Cancer | Index Medicus | Biological Science | 60 APPLIED LIFE SCIENCES
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 12/2009, Volume 170, Issue 12, pp. 1541 - 1554
Discovering and understanding genetic risk factors for melanoma and their interactions with phenotype, sun exposure, and other risk factors could lead to new... 
Environmental exposure | Case-control studies | Family | Genetic predisposition to disease | Risk factors | Melanoma | Ultraviolet radiation | Skin diseases | Population | Genetics | Epidemiology | Public health
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 08/2009, Volume 129, Issue 8, pp. 1983 - 1991
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 2014, Volume 5, Issue 1, pp. 5694 - 5694
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9829, pp. 1893 - 1901
Summary Background Dabrafenib is an inhibitor of BRAF kinase that is selective for mutant BRAF. We aimed to assess its safety and tolerability and to establish... 
Internal Medicine | SURVIVAL | IRRADIATION | MEDICINE, GENERAL & INTERNAL | PATHWAY | RAF INHIBITOR RESISTANCE | B-RAF | MUTATIONS | CANCER | BRAF(V600E) | VEMURAFENIB | Oximes - adverse effects | Humans | Middle Aged | Carcinoma, Squamous Cell - chemically induced | Oximes - administration & dosage | Imidazoles - administration & dosage | Male | Fatigue - chemically induced | Antineoplastic Agents - administration & dosage | Fever - chemically induced | Indoles - administration & dosage | Brain Neoplasms - secondary | Neoplasms - genetics | Antineoplastic Agents - adverse effects | Melanoma - genetics | Adult | Female | Drug Administration Schedule | Imidazoles - adverse effects | Genotype | Treatment Outcome | Skin Neoplasms - chemically induced | Brain Neoplasms - drug therapy | Mutation - genetics | Melanoma - secondary | Neoplasms - drug therapy | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Maximum Tolerated Dose | Indoles - adverse effects | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Sulfonamides - adverse effects | Sulfonamides - administration & dosage | Antimitotic agents | Complications and side effects | Melanoma | Dosage and administration | Metastasis | Antineoplastic agents | Drug therapy | Clinical trials | Medical research | Chemotherapy | Mutation | Toxicity | Tumors | Index Medicus | Abridged Index Medicus
Journal Article